...

Peptide Therapy: A Course for Medical Providers Test #153841

GROUP

Self-paced didactic instruction, treatment protocol development, and practical application

PRICING

Non-refundable $99.99

PRICING

Non-refundable $1099.00

PRICING

Non-refundable $1499.00

LOCATION

Virtual, Online Instruction.

PREREQUISITE

No required prerequisites

Peptide Therapy Certification Course

This comprehensive Peptide Therapy Medical Course is designed for licensed healthcare professionals seeking to expand their knowledge and clinical application of peptide-based treatments. Participants will explore the science of peptides, including their mechanisms of action, therapeutic benefits, safety considerations, and evidence-based uses in patient care.

Course Overview

The course provides an in-depth review of commonly prescribed peptides for wellness, weight management, body composition, recovery, anti-aging, hormone optimization, sexual health, immune support, and regenerative medicine. Learners will gain practical knowledge in patient selection, treatment planning, dosing protocols, administration techniques, monitoring, contraindications, and management of potential adverse effects.

Learning Objectives

  • Explain the physiology and pharmacology of therapeutic peptides.
  • Identify common peptide therapies and their clinical indications.
  • Evaluate patients for peptide therapy candidacy using evidence-based criteria.
  • Develop individualized peptide treatment protocols.
  • Demonstrate safe prescribing, administration, and monitoring practices.
  • Recognize contraindications, precautions, and adverse effects associated with peptide therapies.
  • Apply current research and clinical guidelines to optimize patient outcomes.

Who Should Attend?

Physicians, Nurse Practitioners, Physician Assistants, Registered Nurses, and other licensed healthcare professionals interested in incorporating peptide therapies into clinical practice.

Upcoming Training Dates

Location & Dates

Peptide Therapy: A Course for Medical Providers Test #153841

The clinical course meant to take the bedside clinician to the beautiful world of aesthetics, covering Neuromodulators, Dermal Fillers, Deoxycholic acid, and more!

Accreditation and Designation Statements and Disclosure Report

Neurotoxin: Introduction to History, Mechanism of Action, Facial Anatomy, Injection Technique, and
Management of Adverse Effects

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and the My Face Lady Aesthetic Institute. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

PeerPoint Medical Education Institute designates the enduring format for this educational activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The enduring approval period is: October 14, 2024 – October 14, 2025

Financial Disclosures.
All planners, speakers, reviewers or staff report no relationships to disclose:
“I do not have at present nor have had within the last 24 months, any financial relationships with ineligible companies.”

Accreditation and Designation Statements and Disclosure Report

Dermal Filler: Introduction to Dermal Filler, Mechanism of Action, Facial Anatomy and the Aging Process,
Injection Technique, and Management of Adverse Effects

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and the My Face Lady Aesthetic Institute. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

PeerPoint Medical Education Institute designates the enduring format for this educational activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The enduring approval period is: October 14, 2024 – October 14, 2025

Financial Disclosures.
All planners, speakers, reviewers or staff report no relationships to disclose:
“I do not have at present nor have had within the last 24 months, any financial relationships with ineligible companies.”

Call Now Button